Aptorum Group Ltd Files 6-K Report

Ticker: APM · Form: 6-K · Filed: Oct 8, 2025 · CIK: 1734005

Aptorum Group Ltd 6-K Filing Summary
FieldDetail
CompanyAptorum Group Ltd (APM)
Form Type6-K
Filed DateOct 8, 2025
Risk Levellow
Pages3
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

APM filed a 6-K on Oct 8, 2025, for Q2 2025. Standard foreign private issuer update.

AI Summary

Aptorum Group Ltd filed a Form 6-K on October 8, 2025, reporting for the period ending June 30, 2025. The filing is a report of a foreign private issuer and indicates the company files annual reports under Form 20-F. It also references a previous disclosure concerning Aptorum Group Limited and DiamiR Biosciences Corp.

Why It Matters

This filing provides an update on Aptorum Group's reporting status as a foreign private issuer and references a prior disclosure involving DiamiR Biosciences Corp., which may be relevant for investors tracking the company's ongoing activities and potential collaborations.

Risk Assessment

Risk Level: low — This filing is a routine report of a foreign private issuer and does not appear to contain significant new financial or operational information that would immediately alter risk.

Key Players & Entities

  • Aptorum Group Ltd (company) — Filer of the report
  • DiamiR Biosciences Corp. (company) — Mentioned in an explanatory note regarding previous disclosure
  • October 8, 2025 (date) — Filing date of the report
  • June 30, 2025 (date) — Conformed period of report

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers which provides information that the registrant makes or is required to make public pursuant to the laws of the registrant's home country, or makes or is required to make public by list or distribute to its security holders, or files or is required to file with a stock exchange on which the security is traded.

What is the reporting period for this 6-K filing?

The conformed period of report for this filing is June 30, 2025.

When was this Form 6-K filed with the SEC?

This Form 6-K was filed on October 8, 2025.

Does Aptorum Group Ltd file annual reports under Form 20-F or 40-F?

Aptorum Group Ltd indicates it files annual reports under cover of Form 20-F.

What other company is mentioned in relation to Aptorum Group Ltd in this filing?

DiamiR Biosciences Corp. is mentioned in an explanatory note regarding a previous disclosure.

Filing Stats: 851 words · 3 min read · ~3 pages · Grade level 15.5 · Accepted 2025-10-08 17:01:44

Filing Documents

financial statements of each company and financial statements related to the Merger

financial statements of each company and financial statements related to the Merger. This Form 6-K (including the exhibits hereto) is hereby incorporated by reference into the registration statements of the Company on Form S-8 (Registration Number 333-232591) and Form F-3 (Registration Number 333-268873) and into each prospectus outstanding under the foregoing registration statements, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. Cautionary Note Regarding Forward-Looking This Form 6-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements include, without limitation, statements regarding the financial position, financial performance, business strategy, expectations of our business and the plans and objectives of management for future operations. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this news release, forward-looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "will," "expect," "anticipate," "believe," "seek," "target," "designed to" or other similar expressions that predict or indicate future events or trends or that are not statements of historical facts. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements.

Forward-looking statements are subject to known

Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results could differ materially from those anticipated in forward-looking Report on Form 20-F filed with the U.S. Securities and Exchange Commission. These forward-looking statements are based on information available as of the date of this news release, and expectations, forecasts and assumptions as of that date, involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. 1

Financial Statements and Exhibits

Financial Statements and Exhibits. Exhibits . The following exhibits are attached. Exhibit Description 10.1 Merger Agreement by and between Aptorum and DiamiR, dated July 14, 2025 (incorporated by reference to the Current Report on Form 6-K filed on July 22, 2025) 99.1 Registration Statement on Form S-4 23.1 Consent of CBIZ CPAs P.C. 23.2 Consent of Marcum LLP 101.INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 8, 2025 Aptorum Group Limited By: /s/ Ian Huen Ian Huen Chief Executive Officer 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.